Email updates

Keep up to date with the latest news and content from BMC Infectious Diseases and BioMed Central.

Open Access Research article

A three year descriptive study of early onset neonatal sepsis in a refugee population on the Thailand Myanmar border

Claudia Turner123*, Paul Turner123, Gabie Hoogenboom1, Naw Aye Mya Thein1, Rose McGready123, Kawalee Phakaudom1, Aruni De Zoysa4, Androulla Efstratiou4, Paul T Heath5 and François Nosten123

Author Affiliations

1 Shoklo Malaria Research Unit, Mae Sot 63110, Thailand

2 Mahidol-Oxford Tropical Medicine Research Unit, Bangkok 10400, Thailand

3 Centre for Tropical Medicine, University of Oxford, Oxford OX3 7LJ, United Kingdom

4 Health Protection Agency, Microbiology Services Division, Colindale, London NW9 5EQ, United Kingdom

5 St George’s, University of London, London SW17 0RE, United Kingdom

For all author emails, please log on.

BMC Infectious Diseases 2013, 13:601  doi:10.1186/1471-2334-13-601

Published: 21 December 2013

Abstract

Background

Each year an estimated four million neonates die, the majority in the first week of life. One of the major causes of death is sepsis. Proving the incidence and aetiology of neonatal sepsis is difficult, particularly in resource poor settings where the majority of the deaths occur.

Methods

We conducted a three year observational study of clinically diagnosed early onset (<7 days of age) neonatal sepsis (EONS) in infants born to mothers following antenatal care at the Shoklo Malaria Research Unit clinic in Maela camp for displaced persons on the Thailand-Myanmar border. Episodes of EONS were identified using a clinical case definition. Conventional and molecular microbiological techniques were employed in order to determine underlying aetiology.

Results

From April 2009 until April 2012, 187 infants had clinical signs of EONS, giving an incidence rate of 44.8 per 1000 live births (95% CI 38.7-51.5). One blood culture was positive for Escherichia coli, E. coli was detected in the cerebrospinal fluid specimen in this infant, and in an additional two infants, by PCR. Therefore, the incidence of bacteriologically proven EONS was 0.7 per 1000 live births (95% CI 0.1 – 2.1). No infants enrolled in study died as a direct result of EONS.

Conclusion

A low incidence of bacteriologically proven EONS was seen in this study, despite a high incidence of clinically diagnosed EONS. The use of molecular diagnostics and nonspecific markers of infection need to be studied in resource poor settings to improve the diagnosis of EONS and rationalise antibiotic use.